Peter Patriarca
Bethesda, MDNPI 1194165407
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $144,387 of the $157,975 with a category attached, or 91.4%. 11 manufacturers reported payments, led by Dynavax Technologies Corporation at 40.1% of the total. Reporting peaked in 2020 at $49,089 and has fallen 97.6% since, to $1,200 in 2025.
Across 81 payments — averaging $1950.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Dynavax Technologies Corporation$63K
- Takeda Pharmaceuticals U.S.A., Inc.$27K
- Sanofi-aventis U.S. LLC$19K
- Modernatx, Inc.$10K
- Sanofi Pasteur Inc.$9K
- Seqirus USA Inc$8K
- plus $22K from 5 others
Across 6 payments — averaging $5366.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Takeda Pharmaceuticals U.S.A., Inc.$32K
What the payments were for
- Consulting fees$144,38791%
- Speaking & faculty fees$12,1828%
- Travel & lodging$1,1071%
- Food & beverage$3000%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Dynavax Technologies Corporation | 44 | $63,300 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $26,600 |
| Sanofi-aventis U.S. LLC | 11 | $19,200 |
| Modernatx, Inc. | 1 | $10,000 |
| Sanofi Pasteur Inc. | 4 | $9,224 |
| Seqirus USA Inc | 4 | $7,789 |
| Partner Therapeutics, Inc. | 4 | $5,800 |
| Novavax Inc | 2 | $5,613 |
| Janssen Scientific Affairs, LLC | 2 | $4,500 |
| Sanofi US Services Inc. | 1 | $3,150 |
| ADMA Biomanufacturing LLC | 2 | $2,800 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Heplisav-B$63,300
- PRALUENT$22,350
- Moderna Covid-19 Vaccine$10,000
- Leukine$5,800
- NOVAVAX COVID-19 VACCINE, ADJUVANTED$5,613
- NO PRODUCT DISCUSSED$1,800
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.